Active	Status	Sponsor type	Region	Phase	Filter
15 Active 6 Inactive 21 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Belletrutti, Mark
PRESent-5, NCT05605678: Hemophilia Non-Interventional Study Prior to SerpinPC Intervention	Terminated	N/A	108	Europe, Canada, US, RoW	No Intervention	ApcinteX Ltd, Centessa Pharmaceuticals plc	Hemophilia a, Hemophilia B	11/24	11/24
Beecher, Grayson
ReALiSe, NCT06441682 / 2024-511318-19-00: A Safety and Efficacy Study of ARGX-119 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)	Active, not recruiting	2	60	Europe, Canada	ARGX-119, Placebo	argenx, argenx bv	Amyotrophic Lateral Sclerosis	08/26	08/26
Kaur, Karina
No trials found